Literature DB >> 24054969

UPA > LNG, but Not Good Enough.

Kristina Gemzell-Danielsson1, James Trussell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24054969      PMCID： PMC4097116          DOI： 10.1016/j.contraception.2013.08.007

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  13 in total

1.  Emergency contraception with mifepristone and levonorgestrel: mechanism of action.

Authors:  Lena Marions; Kjell Hultenby; Ingrid Lindell; Xiaoxi Sun; Berit Ståbi; Kristina Gemzell Danielsson
Journal:  Obstet Gynecol       Date:  2002-07       Impact factor: 7.661

2.  Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation.

Authors:  Gabriela Noé; Horacio B Croxatto; Ana María Salvatierra; Verónica Reyes; Claudio Villarroel; Carla Muñoz; Gabriela Morales; Anita Retamales
Journal:  Contraception       Date:  2011-04-27       Impact factor: 3.375

3.  Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study.

Authors:  Natalia Novikova; Edith Weisberg; Frank Z Stanczyk; Horacio B Croxatto; Ian S Fraser
Journal:  Contraception       Date:  2006-10-27       Impact factor: 3.375

4.  Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel.

Authors:  Anna Glasier; Sharon T Cameron; Diana Blithe; Bruno Scherrer; Henri Mathe; Delphine Levy; Erin Gainer; Andre Ulmann
Journal:  Contraception       Date:  2011-04-02       Impact factor: 3.375

5.  Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.

Authors:  Anna F Glasier; Sharon T Cameron; Paul M Fine; Susan J S Logan; William Casale; Jennifer Van Horn; Laszlo Sogor; Diana L Blithe; Bruno Scherrer; Henri Mathe; Amelie Jaspart; Andre Ulmann; Erin Gainer
Journal:  Lancet       Date:  2010-01-29       Impact factor: 79.321

6.  The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle.

Authors:  D Hapangama; A F Glasier; D T Baird
Journal:  Contraception       Date:  2001-03       Impact factor: 3.375

7.  Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture.

Authors:  V Brache; L Cochon; C Jesam; R Maldonado; A M Salvatierra; D P Levy; E Gainer; H B Croxatto
Journal:  Hum Reprod       Date:  2010-07-15       Impact factor: 6.918

8.  Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.

Authors:  Chun-Xia Meng; Karin Louise Andersson; Ursula Bentin-Ley; Kristina Gemzell-Danielsson; P G Luther Lalitkumar
Journal:  Fertil Steril       Date:  2008-01-18       Impact factor: 7.329

9.  Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model.

Authors:  P G L Lalitkumar; S Lalitkumar; C X Meng; A Stavreus-Evers; F Hambiliki; U Bentin-Ley; Kristina Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2007-09-21       Impact factor: 6.918

10.  Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation.

Authors:  H B Croxatto; V Brache; M Pavez; L Cochon; M L Forcelledo; F Alvarez; R Massai; A Faundes; A M Salvatierra
Journal:  Contraception       Date:  2004-12       Impact factor: 3.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.